<p>Molina Healthcare（紐約證券交易所代碼：MOH - 獲取免費報告）在週四早上發佈了 2026 財年的收益指引更新。該公司提供的每股收益指引為 5.000-，而市場共識的每股收益預期為 5.180。該公司發佈的收入指引為-。</p>
<p>獲取 <strong>Molina Healthcare</strong> 的提醒：</p>
<h2>Molina Healthcare 股票表現</h2>
<ul>
<li>3 個下跌時值得購買的行業和 1 個應遠離的行業</li>
</ul>
<p>週四，MOH 股票開盤價為 197.96 美元。該公司的 50 日移動平均線為 172.30 美元，200 日移動平均線為 163.88 美元。Molina Healthcare 的 12 個月低點為 121.06 美元，12 個月高點為 311.52 美元。該公司的市值為 103.1 億美元，市盈率為 58.57，貝塔值為 0.80。該公司的速動比率為 1.63，流動比率為 1.63，債務股本比率為 0.97。</p>
<p>Molina Healthcare（紐約證券交易所代碼：MOH - 獲取免費報告）最近在 4 月 22 日（星期三）發佈了季度財報。該公司報告季度每股收益為 2.35 美元，超出分析師共識預期的 1.57 美元，超出幅度為 0.78 美元。該季度的收入為 108 億美元，而市場共識預期為 109.1 億美元。Molina Healthcare 的淨利潤率為 0.42%，股本回報率為 8.76%。Molina Healthcare 的季度收入同比下降了 3.1%。去年同期，該公司每股收益為 6.08 美元。Molina Healthcare 已將其 2026 財年的指引設定為 5.000-每股收益。整體來看，股票分析師預計 Molina Healthcare 在當前財年將發佈 5.23 美元的每股收益。</p>
<h2>分析師評級變動</h2>
<ul>
<li>Centene 股票為何下跌 40%——現在是否值得購買</li>
</ul>
<p>多家券商對 MOH 進行了評估。富國銀行在 4 月 27 日（星期一）的研究報告中將 Molina Healthcare 的目標價從 141.00 美元上調至 159.00 美元，並給予該股票 “持平” 評級。瑞穗在週一的研究報告中設定了 Molina Healthcare 的目標價為 215.00 美元。美國銀行在 4 月 29 日（星期三）將 Molina Healthcare 的評級從 “表現不佳” 上調至 “買入”，並設定了 250.00 美元的目標價。Cantor Fitzgerald 在 5 月 11 日（星期一）的研究報告中將 Molina Healthcare 的目標價從 144.00 美元上調至 209.00 美元，並給予該公司 “中性” 評級。最後，巴克萊在 5 月 26 日（星期二）的研究報告中將 Molina Healthcare 的目標價從 161.00 美元上調至 199.00 美元，並給予該公司 “減持” 評級。三位研究分析師對該股票給予 “買入” 評級，十一位給予 “持有” 評級，兩位給予 “賣出” 評級。根據 MarketBeat 的數據，該股票目前的平均評級為 “持有”，平均目標價為 182.73 美元。</p>
<p><strong>查看我們對 Molina Healthcare 的最新分析</strong></p>
<h2>內部人士下注</h2>
<ul>
<li>3 只在市場動盪中表現良好的健康保險股票</li>
</ul>
<p>在其他 Molina Healthcare 的新聞中，內部人士 Jeff D. Barlow 在 5 月 11 日（星期一）出售了 17,811 股該股票。股票以 186.12 美元的平均價格出售，總價值為 3,314,983.32 美元。出售完成後，該內部人士直接持有 67,175 股公司股票，價值為 12,502,611 美元。這代表其持股比例下降了 20.96%。該交易在提交給證券交易委員會的文件中披露，文件可在此鏈接查看。此外，首席會計官 Maurice Hebert 在 5 月 14 日（星期四）出售了 600 股公司的股票。該股票以 191.55 美元的平均價格出售，總交易額為 114,930.00 美元。交易完成後，首席會計官持有 12,815 股公司股票，價值約為 2,454,713.25 美元。該交易使其持股比例下降了 4.47%。該銷售的 SEC 文件提供了更多信息。1.44% 的股票由公司內部人士持有。</p>
<h2>對 Molina Healthcare 的對沖基金看法</h2>
<p>對沖基金和其他機構投資者最近對該公司的持倉進行了調整。AQR 資本管理公司在第三季度將其在 Molina Healthcare 的股份增加了 217.0%。AQR 資本管理公司現在擁有 2,934,130 股公司股票，價值為 561,475,000 美元，此前在上個季度增持了 2,008,458 股。T. Rowe Price 投資管理公司在第四季度將其在 Molina Healthcare 的持股增加了 10.2%。T. Rowe Price 投資管理公司現在擁有 2,171,433 股公司股票，價值為 376,831,000 美元，此前增持了 201,772 股。在第四季度，Invesco Ltd.將其在 Molina Healthcare 的持倉增加了 24.2%。Invesco Ltd.現在擁有 1,690,981 股公司股票，價值為 293,453,000 美元，此前增持了 329,679 股。Victory Capital Management Inc.在第四季度將其在 Molina Healthcare 的股份增加了 46.4%。Victory Capital Management Inc.現在擁有 1,410,604 股公司股票，價值為 244,796,000 美元，此前增持了 447,078 股。最後，Dimensional Fund Advisors LP 在第四季度將其在 Molina Healthcare 的股份增加了 20.1%。Dimensional Fund Advisors LP 現在擁有 1,127,761 股公司股票，價值為 195,704,000 美元，此前增持了 189,084 股。98.50% 的股票由機構投資者持有。</p>
<h2>Molina Healthcare 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>Molina Healthcare, Inc 是一家專注於政府資助健康保險項目的管理醫療公司。該公司提供醫療補助管理醫療計劃、醫療保險優勢計劃和根據《平價醫療法案》提供的個人市場計劃。通過綜合護理模式，Molina 強調預防和初級護理服務、護理協調和疾病管理，以改善其成員的健康結果。</p>
<p>該公司的根源可以追溯到 1980 年代初，當時博士。</p>
<h2>另見</h2>
<ul>
<li>五隻我們認為比 Molina Healthcare 更好的股票</li>
<li>隨着股價下跌，分析師們正在提高他們對 Broadcom 的目標價</li>
<li>Everpure：人工智能存儲的不確定性掩蓋了快速增長</li>
<li>這隻科技 ETF 正在超越 QQQ——而加拿大可能是原因之一</li>
<li>英特爾是市場上最被低估的人工智能對沖</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1PSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="325" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1PSA"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Molina Healthcare 嗎？</h2>
<p>在考慮 Molina Healthcare 之前，你會想聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 Molina Healthcare 並不在名單上。</p>
<p>雖然 Molina Healthcare 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

Molina醫療

<p>Molina Healthcare 更新了其 2026 財年的收益指引，將每股收益設定為 5.00 美元以上，低於市場共識預期的 5.18 美元。該公司最近報告了第一季度每股收益為 2.35 美元，超出預期。分析師們調整了目標價，美國銀行將其評級上調至 “買入”，富國銀行也提高了目標價。此外，內部人士 Jeff D. Barlow 和 Maurice Hebert 出售了股份，而像 AQR Capital Management 這樣的機構投資者在最近幾個季度顯著增加了持股</p>

<p>Molina Healthcare (NYSE:MOH - Get Free Report) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided EPS guidance of 5.000- for the period, compared to the consensus EPS estimate of 5.180. The company issued revenue guidance of -.</p>
<div class="lb-trans"><p>Molina Healthcare（紐約證券交易所代碼：MOH - 獲取免費報告）在週四早上發佈了 2026 財年的收益指引更新。該公司提供的每股收益指引為 5.000-，而市場共識的每股收益預期為 5.180。該公司發佈的收入指引為-。</p>
</div><p>Get <strong>Molina Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Molina Healthcare</strong> 的提醒：</p>
</div><h2>Molina Healthcare Stock Performance</h2>
<div class="lb-trans"><h2>Molina Healthcare 股票表現</h2>
</div><ul>
<li>3 Sectors to Buy While They're Down and 1 to Walk Away From</li>
</ul>
<div class="lb-trans"><ul>
<li>3 個下跌時值得購買的行業和 1 個應遠離的行業</li>
</ul>
</div><p>MOH stock opened at $197.96 on Thursday. The firm has a 50 day moving average of $172.30 and a two-hundred day moving average of $163.88. Molina Healthcare has a 12 month low of $121.06 and a 12 month high of $311.52. The company has a market capitalization of $10.31 billion, a price-to-earnings ratio of 58.57 and a beta of 0.80. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.97.</p>
<div class="lb-trans"><p>週四，MOH 股票開盤價為 197.96 美元。該公司的 50 日移動平均線為 172.30 美元，200 日移動平均線為 163.88 美元。Molina Healthcare 的 12 個月低點為 121.06 美元，12 個月高點為 311.52 美元。該公司的市值為 103.1 億美元，市盈率為 58.57，貝塔值為 0.80。該公司的速動比率為 1.63，流動比率為 1.63，債務股本比率為 0.97。</p>
</div><p>Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings results on Wednesday, April 22nd. The company reported $2.35 earnings per share for the quarter, beating analysts' consensus estimates of $1.57 by $0.78. The business had revenue of $10.80 billion for the quarter, compared to the consensus estimate of $10.91 billion. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. Molina Healthcare's revenue for the quarter was down 3.1% on a year-over-year basis. During the same quarter last year, the firm earned $6.08 EPS. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, equities analysts anticipate that Molina Healthcare will post 5.23 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Molina Healthcare（紐約證券交易所代碼：MOH - 獲取免費報告）最近在 4 月 22 日（星期三）發佈了季度財報。該公司報告季度每股收益為 2.35 美元，超出分析師共識預期的 1.57 美元，超出幅度為 0.78 美元。該季度的收入為 108 億美元，而市場共識預期為 109.1 億美元。Molina Healthcare 的淨利潤率為 0.42%，股本回報率為 8.76%。Molina Healthcare 的季度收入同比下降了 3.1%。去年同期，該公司每股收益為 6.08 美元。Molina Healthcare 已將其 2026 財年的指引設定為 5.000-每股收益。整體來看，股票分析師預計 Molina Healthcare 在當前財年將發佈 5.23 美元的每股收益。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析師評級變動</h2>
</div><ul>
<li>Why Centene Stock Dropped 40% — And Whether It's a Buy Now</li>
</ul>
<div class="lb-trans"><ul>
<li>Centene 股票為何下跌 40%——現在是否值得購買</li>
</ul>
</div><p>A number of brokerages have weighed in on MOH. Wells Fargo &amp; Company boosted their price target on Molina Healthcare from $141.00 to $159.00 and gave the stock an &#34;equal weight&#34; rating in a research report on Monday, April 27th. Mizuho set a $215.00 price objective on Molina Healthcare in a research note on Monday. Bank of America upgraded Molina Healthcare from an &#34;underperform&#34; rating to a &#34;buy&#34; rating and set a $250.00 target price for the company in a report on Wednesday, April 29th. Cantor Fitzgerald lifted their price target on shares of Molina Healthcare from $144.00 to $209.00 and gave the company a &#34;neutral&#34; rating in a research report on Monday, May 11th. Finally, Barclays raised their target price on shares of Molina Healthcare from $161.00 to $199.00 and gave the company an &#34;underweight&#34; rating in a research note on Tuesday, May 26th. Three research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of &#34;Hold&#34; and an average target price of $182.73.</p>
<div class="lb-trans"><p>多家券商對 MOH 進行了評估。富國銀行在 4 月 27 日（星期一）的研究報告中將 Molina Healthcare 的目標價從 141.00 美元上調至 159.00 美元，並給予該股票 “持平” 評級。瑞穗在週一的研究報告中設定了 Molina Healthcare 的目標價為 215.00 美元。美國銀行在 4 月 29 日（星期三）將 Molina Healthcare 的評級從 “表現不佳” 上調至 “買入”，並設定了 250.00 美元的目標價。Cantor Fitzgerald 在 5 月 11 日（星期一）的研究報告中將 Molina Healthcare 的目標價從 144.00 美元上調至 209.00 美元，並給予該公司 “中性” 評級。最後，巴克萊在 5 月 26 日（星期二）的研究報告中將 Molina Healthcare 的目標價從 161.00 美元上調至 199.00 美元，並給予該公司 “減持” 評級。三位研究分析師對該股票給予 “買入” 評級，十一位給予 “持有” 評級，兩位給予 “賣出” 評級。根據 MarketBeat 的數據，該股票目前的平均評級為 “持有”，平均目標價為 182.73 美元。</p>
</div><p><strong>Check Out Our Latest Analysis on Molina Healthcare</strong></p>
<div class="lb-trans"><p><strong>查看我們對 Molina Healthcare 的最新分析</strong></p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>內部人士下注</h2>
</div><ul>
<li>3 Health Insurance Stocks Holding Green in Market Turmoil</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只在市場動盪中表現良好的健康保險股票</li>
</ul>
</div><p>In other Molina Healthcare news, insider Jeff D. Barlow sold 17,811 shares of the stock in a transaction on Monday, May 11th. The shares were sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the sale, the insider directly owned 67,175 shares of the company's stock, valued at $12,502,611. This represents a 20.96% decrease in their position. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available at this link. Also, CAO Maurice Hebert sold 600 shares of the business's stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $191.55, for a total transaction of $114,930.00. Following the transaction, the chief accounting officer owned 12,815 shares in the company, valued at approximately $2,454,713.25. The trade was a 4.47% decrease in their position. The SEC filing for this sale provides additional information. 1.44% of the stock is owned by corporate insiders.</p>
<div class="lb-trans"><p>在其他 Molina Healthcare 的新聞中，內部人士 Jeff D. Barlow 在 5 月 11 日（星期一）出售了 17,811 股該股票。股票以 186.12 美元的平均價格出售，總價值為 3,314,983.32 美元。出售完成後，該內部人士直接持有 67,175 股公司股票，價值為 12,502,611 美元。這代表其持股比例下降了 20.96%。該交易在提交給證券交易委員會的文件中披露，文件可在此鏈接查看。此外，首席會計官 Maurice Hebert 在 5 月 14 日（星期四）出售了 600 股公司的股票。該股票以 191.55 美元的平均價格出售，總交易額為 114,930.00 美元。交易完成後，首席會計官持有 12,815 股公司股票，價值約為 2,454,713.25 美元。該交易使其持股比例下降了 4.47%。該銷售的 SEC 文件提供了更多信息。1.44% 的股票由公司內部人士持有。</p>
</div><h2>Hedge Funds Weigh In On Molina Healthcare</h2>
<div class="lb-trans"><h2>對 Molina Healthcare 的對沖基金看法</h2>
</div><p>Hedge funds and other institutional investors have recently made changes to their positions in the business. AQR Capital Management LLC raised its stake in shares of Molina Healthcare by 217.0% in the third quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company's stock valued at $561,475,000 after acquiring an additional 2,008,458 shares during the last quarter. T. Rowe Price Investment Management Inc. grew its holdings in Molina Healthcare by 10.2% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 2,171,433 shares of the company's stock worth $376,831,000 after acquiring an additional 201,772 shares during the period. Invesco Ltd. raised its position in shares of Molina Healthcare by 24.2% during the 4th quarter. Invesco Ltd. now owns 1,690,981 shares of the company's stock valued at $293,453,000 after acquiring an additional 329,679 shares during the last quarter. Victory Capital Management Inc. lifted its stake in shares of Molina Healthcare by 46.4% in the 4th quarter. Victory Capital Management Inc. now owns 1,410,604 shares of the company's stock valued at $244,796,000 after purchasing an additional 447,078 shares during the period. Finally, Dimensional Fund Advisors LP grew its stake in shares of Molina Healthcare by 20.1% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,127,761 shares of the company's stock worth $195,704,000 after purchasing an additional 189,084 shares during the period. 98.50% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>對沖基金和其他機構投資者最近對該公司的持倉進行了調整。AQR 資本管理公司在第三季度將其在 Molina Healthcare 的股份增加了 217.0%。AQR 資本管理公司現在擁有 2,934,130 股公司股票，價值為 561,475,000 美元，此前在上個季度增持了 2,008,458 股。T. Rowe Price 投資管理公司在第四季度將其在 Molina Healthcare 的持股增加了 10.2%。T. Rowe Price 投資管理公司現在擁有 2,171,433 股公司股票，價值為 376,831,000 美元，此前增持了 201,772 股。在第四季度，Invesco Ltd.將其在 Molina Healthcare 的持倉增加了 24.2%。Invesco Ltd.現在擁有 1,690,981 股公司股票，價值為 293,453,000 美元，此前增持了 329,679 股。Victory Capital Management Inc.在第四季度將其在 Molina Healthcare 的股份增加了 46.4%。Victory Capital Management Inc.現在擁有 1,410,604 股公司股票，價值為 244,796,000 美元，此前增持了 447,078 股。最後，Dimensional Fund Advisors LP 在第四季度將其在 Molina Healthcare 的股份增加了 20.1%。Dimensional Fund Advisors LP 現在擁有 1,127,761 股公司股票，價值為 195,704,000 美元，此前增持了 189,084 股。98.50% 的股票由機構投資者持有。</p>
</div><h2>Molina Healthcare Company Profile</h2>
<div class="lb-trans"><h2>Molina Healthcare 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.</p>
<div class="lb-trans"><p>Molina Healthcare, Inc 是一家專注於政府資助健康保險項目的管理醫療公司。該公司提供醫療補助管理醫療計劃、醫療保險優勢計劃和根據《平價醫療法案》提供的個人市場計劃。通過綜合護理模式，Molina 強調預防和初級護理服務、護理協調和疾病管理，以改善其成員的健康結果。</p>
</div><p>The company traces its roots to the early 1980s, when Dr.</p>
<div class="lb-trans"><p>該公司的根源可以追溯到 1980 年代初，當時博士。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另見</h2>
</div><ul>
<li>Five stocks we like better than Molina Healthcare</li>
<li>As Shares Fall, Analyst Are Boosting their Broadcom Price Targets</li>
<li>Everpure: AI Storage Uncertainty Overshadows Breakneck Growth</li>
<li>This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason</li>
<li>Intel Is the Market's Most Mispriced AI Hedge</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們認為比 Molina Healthcare 更好的股票</li>
<li>隨着股價下跌，分析師們正在提高他們對 Broadcom 的目標價</li>
<li>Everpure：人工智能存儲的不確定性掩蓋了快速增長</li>
<li>這隻科技 ETF 正在超越 QQQ——而加拿大可能是原因之一</li>
<li>英特爾是市場上最被低估的人工智能對沖</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1PSA" alt="" original-src="https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx?Prefix=NYSE&amp;Symbol=MOH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Molina Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Molina Healthcare 嗎？</h2>
</div><p>Before you consider Molina Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Molina Healthcare 之前，你會想聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 Molina Healthcare 並不在名單上。</p>
</div><p>While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Molina Healthcare 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Molina 醫療（NYSE:MOH）更新了 2026 財年的收益指引